| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2004 | EP1395585A1 Antibacterial agents |
| 03/10/2004 | EP1395583A1 New phenylpiperazines |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395577A1 Crystal forms of 6- (4-chloro-phenyl)-hydroxy-(-3-methyl-3h-imidaol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production |
| 03/10/2004 | EP1395576A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395572A1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395564A1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395562A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395560A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395552A2 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395550A1 Cycloalkenylsulfonamide derivatives |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395301A1 Crosslinkable macromers |
| 03/10/2004 | EP1395290A2 Cytotoxic cd44 antibody immunoconjugates |
| 03/10/2004 | EP1395289A1 Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists |
| 03/10/2004 | EP1395288A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 03/10/2004 | EP1395287A1 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases |
| 03/10/2004 | EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395280A1 Composition and methods for affecting metallocorrinoid uptake |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395273A1 Targeted delivery of drugs for the treatment of viral infections |
| 03/10/2004 | EP1395270A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 03/10/2004 | EP1395267A2 Therapeutic compositions for modulating the immune response in a mammal and use thereof |
| 03/10/2004 | EP1395266A1 Antiviral nucleoside derivatives |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1395264A2 Targeted delivery of drugs for the treatment of parasitic infections |
| 03/10/2004 | EP1395263A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 03/10/2004 | EP1395262A2 Nucleoside vaccine adjuvants |
| 03/10/2004 | EP1395261A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 03/10/2004 | EP1395260A1 Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395258A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 03/10/2004 | EP1395257A1 Macrocycles useful in the treatment of alzheimer's disease |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1395255A2 Cddo-compounds and combination therapies thereof |
| 03/10/2004 | EP1395254A1 Oral pharmaceutical composition containing a statin derivative |
| 03/10/2004 | EP1395253A2 Treatment of anxiety disorders |
| 03/10/2004 | EP1395252A1 Medicaments for treating colics |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | EP1395249A1 Soft elastic capsules comprising ritonavir and/or lopinavir |
| 03/10/2004 | EP1395247A2 Oxcarbazepine dosage forms |
| 03/10/2004 | EP1395244A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/10/2004 | EP1395243A2 Encapsulation of nanosuspensions in liposomes and microspheres |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | EP1395240A1 Modification of the sustained release profile |
| 03/10/2004 | EP1395239A1 Cosmetic or dermatological preparations containing one or more ketohexoses |
| 03/10/2004 | EP1395238A1 Skin preparation |
| 03/10/2004 | EP1395231A1 Preparation for the removal of abnormal keratin material |
| 03/10/2004 | EP1395215A1 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/10/2004 | EP1395127A1 Health feed |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | EP1274713B1 Anti-viral pyrimidine nucleoside analogues |
| 03/10/2004 | EP1237855B1 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 03/10/2004 | EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells |
| 03/10/2004 | EP1231911B1 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 03/10/2004 | EP1177196B1 Heteroaryl diazabicycloalkanes, their preparation and use |
| 03/10/2004 | EP1163244B1 Thienopyrimidine compounds, their production and use |
| 03/10/2004 | EP1140942B1 Prenyl transferase inhibitors |
| 03/10/2004 | EP1121348B1 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents |
| 03/10/2004 | EP1112275B9 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/10/2004 | EP1100499B1 Use of eletriptan for the prevention of migraine recurrence |
| 03/10/2004 | EP1087769B1 Use of a pyridazinone derivative as calcium sensitizer |
| 03/10/2004 | EP1084120B1 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents |
| 03/10/2004 | EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii |
| 03/10/2004 | EP1071693B1 Novel crystalline forms of an antiviral benzimidazole compound |
| 03/10/2004 | EP1066044B1 Dextran formulations for treatment of inflammatory joint disorders |
| 03/10/2004 | EP1054673B1 Benzoxazine compounds for enhancing synaptic response |
| 03/10/2004 | EP1030660B1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 03/10/2004 | EP0994875B1 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders |
| 03/10/2004 | EP0983256B1 Triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/10/2004 | EP0980245B1 Use of misoprostol or/and misoprostol acid for the treatment of erectile dysfunction |
| 03/10/2004 | EP0957911B1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 03/10/2004 | EP0909330B1 Diagnostic method and apparatus |
| 03/10/2004 | EP0873050B1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 03/10/2004 | EP0854729B1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/10/2004 | EP0854718B1 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 03/10/2004 | EP0804435B1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 03/10/2004 | EP0792147B1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
| 03/10/2004 | EP0769955B1 Non-antigenic amine derived polymers and polymer conjugates |
| 03/10/2004 | EP0767634B1 Microcapsules for administration of neuroactive agents |